Aller au contenu

Design of a randomized controlled phase III study of dose dense methotrexate, vinblastine, doxorubicin and cisplatin (dd-MVAC) or gemcitabine and cisplatin (GC) as peri-operative chemotherapy for patients with locally advanced transitional cell cancer of the bladder. The French GETUG/AFU V05 VESPER trial

Nom du journal : Contemp Clin Trials Commun

Année : 2020

Volume : 17

Page de départ : 100536

Auteurs: Allory Y, Harter V, Pfister C, Culine S, Radvanyi F, VESPER Trial Investigators,